Insights Into the North American Cancer Registry Software Market, 2020 - Research Institutes Anticipated to Grow at a Lucrative Rate to 2025

DUBLIN, March 20, 2020 /PRNewswire/ -- The "North America Cancer Registry Software Market, by Type, by Deployment Type, by Component, by End User, by Country, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

The North America Cancer Registry Software Market is expected to witness market growth of 9.81% CAGR during the forecast period (2019-2025).

Owing to the existence of developed infrastructure, North America recorded the largest revenue share on the cancer registry software market in 2018. Increasing cancer incidence in this area due to tobacco smoking and lack of physical activity among others is driving growth in the marketplace.

Hospital cancer registry will help physicians determine the outcomes of the therapy and schedule treatment accordingly. The developed and growing countries are working to implement the program in all hospitals to monitor the disease and provide a framework for impact assessment and control. Nonetheless, issues related to data protection, privacy policies, and low awareness may restrain the market growth in the near future.

As of 2018, the government & third party retained the largest share of the end-use segment. Increasing the adoption of this software by governments of developed as well as developing countries to ease the burden of cancer are accelerating market growth. Using this registry, governments can easily track the areas most affected and take proactive measures. In addition, increasing government support for software implementation in hospitals is raising revenue in the segment.

The research institutes segment is anticipated to grow at a lucrative growth rate over the forecast period due to increased research initiatives being undertaken by government and private organizations to address the growing cancer incidence. These institutes utilize software to track patients for clinical trials and to control the success of treatment programs. Companies in the pharmaceutical, biotechnology, & medical devices sector are also expected to show significant growth over the forecast period due to these industries growing their R&D for better treatment outcomes.

Key Topics Covered

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cancer Registry Software Market, by Type
1.4.2 North America Cancer Registry Software Market, by Deployment Type
1.4.3 North America Cancer Registry Software Market, by Component
1.4.4 North America Cancer Registry Software Market, by End User
1.4.5 North America Cancer Registry Software Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Cancer Registry Software Market by Type
3.1 North America Integrated Cancer Registry Software Market by Country
3.2 North America Standalone Cancer Registry Software Market by Country

Chapter 4. North America Cancer Registry Software Market by Deployment Model
4.1 North America On-premise Cancer Registry Software Market by Country
4.2 North America Cloud-based Cancer Registry Software Market by Country

Chapter 5. North America Cancer Registry Software Market by Component
5.1 North America Commercial Cancer Registry Software Market by Country
5.2 North America Public Cancer Registry Software Market by Country

Chapter 6. North America Cancer Registry Software Market by End User
6.1 North America Government & Third party Market by Country
6.2 North America Research Centers Market by Country
6.3 North America Hospital & Medical Centers Market by Country
6.4 North America Private Payers Market by Country
6.5 North America Pharma biotech & medical device suppliers Market by Country

Chapter 7. North America Cancer Registry Software Market by Country
7.1 USA Cancer Registry Software Market
7.1.1 USA Cancer Registry Software Market by Type
7.1.2 USA Cancer Registry Software Market by Deployment Model
7.1.3 USA Cancer Registry Software Market by Component
7.1.4 USA Cancer Registry Software Market by End User
7.2 Canada Cancer Registry Software Market
7.3 Mexico Cancer Registry Software Market
7.4 Rest of North America Cancer Registry Software Market

Chapter 8. Company Profiles
8.1 IBM Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 McKesson Corporation
8.3 Conduent, Incorporated
8.4 Elekta AB
8.5 Ordinal Data, Inc.
8.6 Onco, Inc.
8.7 C/Net Solutions
8.8 Rocky Mountain Cancer Data System
8.9 Electronic Registry System, Inc.
8.10 Himagine Solutions, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/1l50n

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/insights-into-the-north-american-cancer-registry-software-market-2020---research-institutes-anticipated-to-grow-at-a-lucrative-rate-to-2025-301027467.html

SOURCE Research and Markets